Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | AMGN | MRNA | GILD | BNTX |
| Company | Bristol-Myers Squibb Company | Amgen Inc | Moderna Inc | Gilead Sciences Inc | Biontech Se ADR |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 47.39 | 273.45 | 107.43 | 67.47 | 87.98 |
| High | 47.50 | 274.35 | 108.23 | 67.90 | 88.24 |
| Low | 44.67 | 267.24 | 103.52 | 65.32 | 86.13 |
| Last | 45.05 | 268.17 | 104.99 | 65.54 | 86.59 |
| Change | -3.81 | -4.84 | -3.86 | -1.54 | -1.50 |
| % Change | -7.80% | -1.77% | -3.55% | -2.30% | -1.70% |
| Volume | 21,980,441 | 531,279 | 1,362,541 | 4,069,465 | 160,875 |
| 20-Day Average Volume | 11,638,183 | 2,084,862 | 3,062,852 | 6,295,121 | 567,020 |
| Previous Close | 48.86 | 273.01 | 108.85 | 67.08 | 88.09 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 49.95 | 270.63 | 104.91 | 68.71 | 88.74 |
| 20-Day Raw Stochastic | 2.86% | 26.21% | 39.07% | 4.33% | 17.29% |
| 20-Day Relative Strength | 28.85% | 43.63% | 50.95% | 29.30% | 41.71% |
| Weighted Alpha | -34.22 | +8.34 | -13.47 | -23.05 | -25.31 |
| Today's Opinion | 88% Sell | 72% Sell | 88% Buy | 100% Sell | 100% Sell |
| Previous Opinion | 88% Sell | 40% Sell | 88% Buy | 100% Sell | 100% Sell |
| Last Month's Opinion | 8% Sell | 24% Buy | 72% Buy | 88% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.94% since 04/18/24 | +1.99% since 04/18/24 | +2.33% since 04/18/24 | -0.71% since 04/18/24 | +0.80% since 04/18/24 |
| Low | 44.67 on 04/25/24 | 260.68 on 04/19/24 | 99.30 on 04/22/24 | 65.32 on 04/25/24 | 85.63 on 04/19/24 |
| High | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 111.29 on 04/24/24 | 67.78 on 04/25/24 | 89.52 on 04/23/24 |
| 1-Month | |||||
| %Chg | -13.97% since 03/25/24 | -4.57% since 03/25/24 | -5.44% since 03/25/24 | -9.49% since 03/25/24 | -6.60% since 03/25/24 |
| Low | 44.67 on 04/25/24 | 260.68 on 04/19/24 | 97.00 on 04/03/24 | 65.32 on 04/25/24 | 85.40 on 04/17/24 |
| High | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 115.89 on 04/09/24 | 73.87 on 03/28/24 | 93.84 on 03/28/24 |
| 3-Month | |||||
| %Chg | -9.39% since 01/25/24 | -13.62% since 01/25/24 | +1.53% since 01/25/24 | -18.12% since 01/25/24 | -10.36% since 01/25/24 |
| Low | 44.67 on 04/25/24 | 260.68 on 04/19/24 | 84.06 on 02/13/24 | 65.32 on 04/25/24 | 85.21 on 03/20/24 |
| High | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 115.89 on 04/09/24 | 80.51 on 01/26/24 | 97.50 on 03/11/24 |
| 6-Month | |||||
| %Chg | -20.60% since 10/25/23 | -1.53% since 10/25/23 | +35.98% since 10/25/23 | -16.20% since 10/25/23 | -8.81% since 10/25/23 |
| Low | 44.67 on 04/25/24 | 249.70 on 10/31/23 | 62.55 on 11/02/23 | 65.32 on 04/25/24 | 85.21 on 03/20/24 |
| High | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 115.97 on 01/08/24 | 87.86 on 01/19/24 | 114.69 on 01/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 99,027,448 | 146,436,016 | 41,676,488 | 83,519,768 | 20,941,282 |
| Shares Outstanding, K | 2,026,759 | 536,376 | 382,880 | 1,245,077 | 237,726 |
| Annual Sales | 45,006,000,000 | 28,190,000,000 | 6,848,000,000 | 27,116,000,000 | 4,133,300,000 |
| Annual Net Income | 8,025,000,000 | 6,717,000,000 | -4,714,000,000 | 5,665,000,000 | 1,006,860,000 |
| Last Quarter Sales | 11,477,000,000 | 8,196,000,000 | 2,811,000,000 | 7,114,000,000 | 1,605,270,000 |
| Last Quarter Net Income | 1,762,000,000 | 767,000,000 | 217,000,000 | 1,429,000,000 | 500,620,000 |
| 60-Month Beta | 0.39 | 0.58 | 1.62 | 0.19 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.55 on 02/22/24 | 1.72 on 02/06/24 | 2.05 on 03/20/24 |
| Latest Earnings Date | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 | 3.084 on 06/02/22 |
| Next Ex-Dividends Date | 04/04/24 | 05/16/24 | N/A | 03/14/24 | 06/02/22 |
| Ratios | |||||
| Price/Earnings ttm | 6.53 | 14.67 | 0.00 | 9.97 | 21.48 |